AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2022-03-01. The company is focused on developing and commercializing a suite of genomic tests that support decision-making along the entire continuum of oncology care. The company focuses on its proprietary genomic tests, MicroRNA Signature Classifier (MSC) for patients with lung nodules and StemPrintER for patients with early-stage breast cancer. The MSC test, a 24-micro-RNA (miRNA) assay designed to help determine whether lung nodules identified by low-dose computer tomography (LDCT) screening, are benign or malignant. StemPrintER, a 20-gene prognostic assay intended to predict the risk of distant recurrence (DR) in luminal (ER+/HER2-negative) breast cancer patients. The assay is developed to measure the stemness of tumors, or how much a tumor behaves like stem cells, which could indicate how likely a cancer is to recur or be resistant to standard treatments, ultimately impacting how patients are managed by their multidisciplinary care team.
ACUT stock price ended at $0.63 on Cuma, after dropping 3.08%
On the latest trading day Jan 23, 2026, the stock price of ACUT fell by 3.08%, dropping from $0.64 to $0.63. During the session, the stock saw a volatility of 3.23%, with prices oscillating between a daily low of $0.62 and a high of $0.64. On the latest trading day, the trading volume for ACUT rose by 147 shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 1.2K shares were traded, with a market value of approximately $10.1M.
ACUTTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 2
Nötr Sinyaller 1
Satış Sinyalleri 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
ACUT, şu anda 2 alım sinyali ve 4 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Aşağı yönlü trend durumundadır ve bu dönemde toplam -3.08% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Sell görünüm işaret etmektedir.
ACUT için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek ACUT için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.
Takip Soruları
Teknik analiz göstergeleri ACUT için nasıl uygulanır?
ACUT için Fibonacci geri dönüş seviyeleri nelerdir?
Accustem Sciences Inc için RSI nedir?
Önümüzdeki 12 ay için Accustem Sciences Inc fiyatı nedir?
Accustem Sciences Inc ne kadar yükselmesi bekleniyor?